Stock Performance and Market Context
On 8 December 2025, Entero Healthcare Solutions recorded its lowest price in the past year at Rs.1015. This level represents a notable drop from its 52-week high of Rs.1564.95. Over the last three trading sessions, the stock has registered a cumulative return of -2.8%, underperforming its retailing sector peers by approximately 1.04% on the day of the new low.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a sustained downward trend in price momentum. This contrasts with the broader market, where the Sensex opened flat but later declined by 242.55 points, or 0.39%, closing at 85,382.29. Notably, the Sensex remains close to its 52-week high, trading just 0.91% below the peak of 86,159.02, and is positioned above its 50-day moving average, which itself is above the 200-day moving average, signalling a generally bullish market environment.
Long-Term and Recent Returns
Entero Healthcare Solutions has experienced a negative return of 30.34% over the past year, a stark contrast to the Sensex’s positive 4.51% return during the same period. This divergence highlights the stock’s relative underperformance within the broader market. Additionally, the company’s returns have lagged behind the BSE500 index over the last three years, one year, and three months, underscoring persistent challenges in maintaining competitive performance.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
See What's Driving the Rally →
Financial Health and Operational Metrics
Despite the stock’s price decline, Entero Healthcare Solutions demonstrates a capacity to manage its financial obligations effectively. The company’s Debt to EBITDA ratio stands at 1.33 times, indicating a relatively low leverage position and a strong ability to service debt. This financial metric suggests that the company maintains prudent capital management amid fluctuating market conditions.
Over the long term, the company’s net sales have expanded at an annual rate of 30.10%, while operating profit has shown a substantial rise of 127.38%. These figures reflect a healthy growth trajectory in core business operations. The company has also reported positive results for seven consecutive quarters, with quarterly net sales reaching a peak of Rs.1,570.95 crore and quarterly PBDIT (Profit Before Depreciation, Interest and Taxes) attaining Rs.62.06 crore. The operating profit to net sales ratio for the quarter stands at 3.95%, marking the highest level recorded in recent periods.
Valuation and Profitability Indicators
Entero Healthcare Solutions holds a return on capital employed (ROCE) of 8.6%, which is considered attractive within its sector. The company’s enterprise value to capital employed ratio is 2.3, suggesting a valuation that is lower than the average historical valuations of its peers. This discount in valuation may reflect market caution given the stock’s recent price movements.
Over the past year, while the stock price has declined by 30.34%, the company’s profits have risen by 142%. This disparity is highlighted by a price/earnings to growth (PEG) ratio of 0.3, indicating that profit growth has outpaced the stock price performance during this period.
Shareholding and Market Position
Institutional investors hold 24.32% of Entero Healthcare Solutions’ shares. These investors typically possess greater resources and analytical capabilities to assess company fundamentals, which may influence market perceptions and trading activity.
Is Entero Healthcare Solutions your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Current Market Standing
Entero Healthcare Solutions’ stock price decline to Rs.1015 marks a significant point in its recent trading history, reflecting a period of subdued market performance relative to the broader indices and sector peers. While the stock has underperformed over the past year and longer horizons, the company’s financial metrics indicate ongoing growth in sales and profitability, alongside a manageable debt profile.
The contrast between the company’s operational results and its stock price suggests a complex market environment where valuation and investor sentiment may be influenced by multiple factors beyond immediate financial performance. The stock’s position below all major moving averages further emphasises the current downward price trend.
As the retailing sector continues to navigate market dynamics, Entero Healthcare Solutions remains a notable entity with a mixed profile of financial strength and recent price weakness.
Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
